This study revealed for the first time that blood sLRP1 levels, which predict cardiovascular risk (9), are upregulated, while ANP levels, which inversely predict metabolic risk (21–23), are downregulated in T2DM patients at disease onset as compared to healthy controls. Here, NPPA is linked to type 2 diabetes mellitus.